Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus

American Journal of the Medical Sciences

Volumn 328, Issue 3, 2004, Pages 150-155

  Hsu, Ron Bin ^a   Chu, Shu Hsun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Infective endocarditis; Methicillin resistance; Staphylococcus aureus

Indexed keywords

METICILLIN;

ADULT; AGING; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; COMORBIDITY; EMBOLISM; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PENICILLIN RESISTANCE; PREDICTION; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMIC DISEASE; SYSTEMIC EMBOLISM; TAIWAN; TREATMENT OUTCOME; UNDERLYING DISEASE;

EID: 4644315254     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200409000-00003     Document Type: Article

References (32)

1. Netzer RO, Altwegg SC, Zollinger E, et al. Infective endocarditis: determinants of long term outcome. Heart 2002;88:61-6.
2. Bouza E, Menasalvas A, Munoz P, et al. Infective endocarditis-a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine 2001;80:298-307.
3. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81.
4. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis. Arch Intern Med 1986;146:1118-21.
5. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4.
6. Roder BL, Wandall DA, Frimodt-Moller N, et al. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999;159:462-9.
7. Sanabria TJ, Alpert JS, Goldberg R, et al. Increasing frequency of staphylococcal infective endocarditis. Arch Intern Med 1990;150:1305-9.
8. Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999;28:106-14.
9. Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002;8:602-7.
10. Gentry CA, Rodvold KA, Novak RM, et al. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy 1997;17:990-7.
11. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674-80.
12. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
13. Wang JT, Chang SC, Ko WJ, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001;47:104-9.
14. Bishara J, Leibovici L, Gartman-Israel D, et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis 2001;331636-43.
15. Heiro M, Nikoskelainen J, Engblom E, et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000;160:2781-7.
16. Roder BL, Wandall DA, Espersen F, et al. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997;102:379-86.
17. Millaire A, Leroy O, Gaday V, et al. Incidence and prognosis of embolic events and metastatic infections in infective endocarditis. Eur Heart J 1997;18:677-84.
18. Ringberg H, Thoren A, Lilija B. Metastatic complications of Staphylococcus aureus septicemia. To seek is to find. Infection 2000;28:132-6.
19. O'Brien L, Kerrigan SW, Kaw G, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: role for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002;44:1033-44.
20. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489-95.
21. Vaudaux PE, Monzillo V, Francois P, et al. Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesions. Antimicrol Agents Chemother 1998;42:564-70.
22. McGowan JE Jr, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297-311.
23. Hsueh PR, Chen ML, Sun CC, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002;8:63-8.
24. Wang JT, Chen YC, Yang TL, et al. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002;42:199-203.
25. Rezende NA, Blumberg HM, Metzger BS, et al. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002;323:117-23.
26. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000;160:1001-4.
27. Talon D, Woronoff-Lemsi MC, Limat S, et al. The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 2002;13:31-6.
28. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000;30:368-73.
29. Harbarth S, Rutschmann O, Sudre P, et al. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182-9.
30. Romero-Vivas J, Rubio M, Fernandez C, et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:1417-23.
31. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control 1985;13:109-14.
32. Chang FY, MacDonald BB, Peacock JE Jr, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003;82:322-32.